Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascletis' Ganovo Enrolled in the Basic Medical Insurance of Chengdu 2019-01-02 08:00
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Esophageal Cancer 2019-01-02 08:00
Thailand Board of Investment Pushes Thai GDP Growth by Over Bt400 Billion 2018-12-28 16:40
JHL Biotech Announces First Patient Randomized in the Phase III Study of JHL1101 to Treat Diffuse Large B-Cell Lymphoma 2018-12-28 04:00
Focusing on CRO & CMO Industry Upgrading, ICSE China 2019 Helps Enterprises Seize New Industry Opportunities 2018-12-25 15:00
Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer 2018-12-22 03:14
Rakuten Aspyrian Closes $284 Million Series C Financing for Late-Stage Oncology Pipeline 2018-12-21 09:00
Merck Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon 2018-12-20 21:06
Allergan Suspends Sales and Withdraws Supply of Textured Breast Implants in European Markets 2018-12-19 21:44
Hycor Biomedical Receives FDA 510(k) Clearance for NOVEOS™, Its Modern Allergy Testing Instrument 2018-12-19 21:07
Gan & Lee and a Leading Pharmaceutical Company Enters into Global Collaboration to Commercialize Insulin Analog 2018-12-19 19:22
Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform 2018-12-18 23:00
PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion For Besremi(™) (Ropeginterferon alfa-2b) For Treatment Of Polycythemia Vera (PV) In EU 2018-12-17 16:00
BioNet reports on persistence of antibody responses of recombinant pertussis vaccines in the Lancet Infectious Diseases 2018-12-17 15:36
Frost & Sullivan Publishes Q3-2018 Update On Cellect Biotechnology Ltd. 2018-12-14 02:18
With the Chinese API Market Growing, CPhI China Assists Enterprises with Transformation, Innovation, and Comprehensive Upgrading 2018-12-13 15:00
WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange 2018-12-13 10:23
WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity 2018-12-12 08:08
Tissue Genesis Introduces State-of-the-Art Icellator(R) X 2018-12-11 23:00
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 15:00
1 184 185 186 187 188 224